1. Home
  2. PHVS vs JBSS Comparison

PHVS vs JBSS Comparison

Compare PHVS & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • JBSS
  • Stock Information
  • Founded
  • PHVS 2015
  • JBSS 1959
  • Country
  • PHVS Switzerland
  • JBSS United States
  • Employees
  • PHVS N/A
  • JBSS N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • JBSS Specialty Foods
  • Sector
  • PHVS Health Care
  • JBSS Consumer Staples
  • Exchange
  • PHVS Nasdaq
  • JBSS Nasdaq
  • Market Cap
  • PHVS 909.5M
  • JBSS 794.3M
  • IPO Year
  • PHVS 2021
  • JBSS 1991
  • Fundamental
  • Price
  • PHVS $17.99
  • JBSS $63.18
  • Analyst Decision
  • PHVS Buy
  • JBSS
  • Analyst Count
  • PHVS 6
  • JBSS 0
  • Target Price
  • PHVS $37.17
  • JBSS N/A
  • AVG Volume (30 Days)
  • PHVS 62.5K
  • JBSS 64.6K
  • Earning Date
  • PHVS 08-13-2025
  • JBSS 08-19-2025
  • Dividend Yield
  • PHVS N/A
  • JBSS 3.32%
  • EPS Growth
  • PHVS N/A
  • JBSS N/A
  • EPS
  • PHVS N/A
  • JBSS 4.72
  • Revenue
  • PHVS N/A
  • JBSS $1,107,742,000.00
  • Revenue This Year
  • PHVS N/A
  • JBSS N/A
  • Revenue Next Year
  • PHVS N/A
  • JBSS N/A
  • P/E Ratio
  • PHVS N/A
  • JBSS $13.38
  • Revenue Growth
  • PHVS N/A
  • JBSS 7.40
  • 52 Week Low
  • PHVS $11.51
  • JBSS $58.47
  • 52 Week High
  • PHVS $25.50
  • JBSS $105.63
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 58.65
  • JBSS 51.18
  • Support Level
  • PHVS $16.00
  • JBSS $62.07
  • Resistance Level
  • PHVS $17.53
  • JBSS $65.73
  • Average True Range (ATR)
  • PHVS 1.14
  • JBSS 1.38
  • MACD
  • PHVS 0.01
  • JBSS 0.17
  • Stochastic Oscillator
  • PHVS 59.77
  • JBSS 49.30

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: